FindTrial
Sign In

Effect of baru consumption on the blood fat profile of people with excess body fat and its relationship with genetics.

Effect of baru seed consumption on lipid profile of individuals with excess body fat: relation with apolipoprotein E genotype

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-24td8t
Enrollment
Unknown
Registered
2020-08-26
Start date
2016-08-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias Apolipoprotein E4 Genetic polymorphism

Interventions

Number of participants: Each group was composed by 18 individuals, totaling 36 participants. Procedures/supplementation: All subjects were supplemented with 20 grams of toasted baru almond, daily (del
Dietary supplement
B01.650.940.800.575.100.401.194
SP6.051.227

Sponsors

Faculdade de Medicina da Universidade Federal de Goiás
Lead Sponsor
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Collaborator

Eligibility

Age
20 Years to 59 Years

Inclusion criteria

Inclusion criteria: The sample of this study included individuals between 20 and 59 years (age range adopted in the matrix study) who agreed to participate in the study, with BMI between 18.5 kg/m² and 24.99 kg/m² (WHO, 2005), percentage of body fat above the established parameters, according to sex and age range (POLLOCK; WILMORE, 1993), who did not habitually consume nuts (more than twice a week) and had increased cholesterol in low-density lipoproteins (LCL-C) serum concentrations, according to the Brazilian Society of Cardiology (SBC, 2013), confirmed by biochemical exams .

Exclusion criteria

Exclusion criteria: Individuals taking lipid-lowering drugs and/or vitamin and mineral supplements; who had allergies to nuts; under nutritional accompaniment; women who were pregnant, in menopause or hormone replacement therapy; patients presenting with acute clinical conditions such as infection, inflammation, fever or diarrhea, or chronic diseases such as diabetes mellitus, moderate/severe arterial hypertension, cancer, rheumatoid arthritis; subjects who were smokers or practiced moderate to intense physical activity.

Design outcomes

Primary

MeasureTime frame
Reduction in total cholesterol concentrations, assessed by examining serum lipid profile, of at least 10% in relation to the initial values.;Difference in serum lipid concentrations between individuals carrying different apolipoprotein E genotypes (E4 allele carriers x E4 allele non-carriers).—

Secondary

MeasureTime frame
Difference in serum lipid concentrations between individuals carrying different apolipoprotein E genotypes (E4 allele carriers x E4 allele non-carriers).—

Countries

Brazil

Contacts

Public ContactCristiane Cominetti

Universidade Federal de Goiás

ccominetti@ufg.br55-62-320096270

Outcome results

None listed

Source: REBEC (via WHO ICTRP)